Subscribe To
Angion (angn) kidney drug misses third study goal in 2021
Angion's (ANGN) phase II study evaluating ANG-3777 in cardiac surgery-associated acute kidney injury fa...
December 13, 2021, 1:50 pm
Angion (angn) kidney drug misses third study goal in 2021
Angion's (ANGN) phase II study evaluating ANG-3777 in cardiac surgery-associated acute kidney injury fa...
December 13, 2021, 1:50 pm
Researchers identify thymosin beta 4's potential role in treatment of acute kidney injury and the reduction of mortality in patients with sepsis
ROCKVILLE, Md., Oct. 6, 2021 /PRNewswire/ -- RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("RegeneRx"), a clinical-stage drug development company...
October 6, 2021, 9:20 am
Researchers identify thymosin beta 4's potential role in treatment of acute kidney injury and the reduction of mortality in patients with sepsis
ROCKVILLE, Md., Oct. 6, 2021 /PRNewswire/ -- RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("RegeneRx"), a clinical-stage drug development company...
October 6, 2021, 9:20 am
Researchers identify thymosin beta 4's potential role in treatment of acute kidney injury and the reduction of mortality in patients with sepsis
ROCKVILLE, Md., Oct. 6, 2021 /PRNewswire/ -- RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("RegeneRx"), a clinical-stage drug development company...
October 6, 2021, 9:20 am